CLASS II ONGOING Drug recall · Reported 12 Feb 2025 · FDA Enforcement Report

Timolol Maleate Ophthalmic Solution USP, 5%, Sterile recalled by FDC

FDC is recalling Timolol Maleate Ophthalmic Solution USP, 5%, Sterile, distributed in New Jersey. The recall was initiated on 23 Jan 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: 083J033, Exp. Date 09/2025
NDC64980-513, 64980-514
UPC0364980513050
Quantity recalled118104 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0214-2025
FDA event ID
96196
Recalling firm
FDC, Aurangabad, Maharashtra State
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
23 Jan 2025
FDA classified
31 Jan 2025
Reported
12 Feb 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Eye Drops

Timeline

23 Jan 2025Recall initiated by company
31 Jan 2025Classified by FDA+8 days
12 Feb 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.

Where it was distributed

Distributed to one (1) Us Distributor in NJ

New Jersey

Questions about this recall

Is Timolol Maleate Ophthalmic Solution USP, 5%, Sterile recalled?

Yes. FDC recalled Timolol Maleate Ophthalmic Solution USP, 5%, Sterile on 23 Jan 2025. The recall is Class II and its status is Ongoing. Recall number D-0214-2025.

Why was it recalled?

Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Which lots are affected?

Lot#: 083J033, Exp. Date 09/2025

Where was it sold?

Distributed to one (1) Us Distributor in NJ

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from FDC

All 11

Other Timolol recalls

All 11